Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Double Dose Tamsulosin in BPH
NCT05834270Completed
- Sponsor
- Menoufia University
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Menoufia University. Primary endpoint: Change in the lower urinary tract symptoms at 3 months. Started May 2022; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT05834270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05834270.